In the Phase 2b trials, this combination therapy achieved a 49% decrease in the risk of recurrence or death relative to ...

Jan 22 (Reuters) - Moderna does not plan to invest in new late-stage vaccine trials because of growing opposition to ...

Before COVID, few people had heard of Moderna. They were a quiet underdog with a mission that sounded like science fiction: ...

In a small clinical trial, customized mRNA vaccines against high-risk skin cancers appeared to reduce the risk of cancer recurrence and death by nearly 50 percent over five years when compared with ...

The companies have an expansive clinical program for the mRNA neoantigen therapy intismeran autogene in combination with ...

The firm is expecting a slew of key readouts for mRNA vaccines for treating cancer and rare diseases and is exploring vaccines for autoimmune conditions.

The complaint alleges that Moderna used the patented fluorescent protein technology without permission during preclinical ...

Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 8.8% in the afternoon session after the company, in partnership ...

The vaccines subsector received a big fillip from Covid, but its potential extends far beyond combating pandemics. Dr Mike ...

What To Know: A memo obtained by NBC News said Prasad told FDA staff that an internal review found at least 10 child deaths "after and because of receiving" the Covid vaccine, citing reports in the ...

Dr. Mani Foroohar, Leerink Partners, joins 'Closing Bell Overtime' to talk Moderna prices climbing on positive drug trial.